MELINDA CLARK: Open Payments
NPI 1285910653 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 124 payments from 37 companies in 2025. Trend: 2023 $3,149 · 2024 $2,742 · 2025 $2,497
Food & beverage: $2,497
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $288 |
| Merck Sharp & Dohme LLC | 9 | $206 |
| Novartis Pharmaceuticals Corporation | 12 | $201 |
| E.R. Squibb & Sons, L.L.C. | 11 | $190 |
| Daiichi Sankyo Inc. | 5 | $130 |
| Incyte Corporation | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Celgene Corporation | 4 | $85 |
| Janssen Biotech, Inc. | 4 | $75 |
Products named: KEYTRUDA, OPDIVO, EPKINLY, KISQALI, IBRANCE, Nubeqa, ENHERTU, Trodelvy.
Industry payments across MS — which companies pay providers there.
